On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.

This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters. Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration.

Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.

Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their preferred methodologies for tracking long-term treatment, and identify areas where primary eye care providers could improve the quality of care.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.

Jay Patel, MD, recaps his article, “Masqueraders of Normal-Tension Glaucoma,” coauthored with Amanda D. Henderson, MD, and featured in the May/June issue of Glaucoma Today. The article outlines several types of nonglaucomatous optic neuropathy that should be considered in patients with gradually progressive optic neuropathy.

Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.

David Solá-Del Valle, MD, recaps his article—“Is Glaucoma Policy Short-Sighted?”—which was written with Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; and Henisk Falah, BS, and featured in the March/April issue of Glaucoma Today. In their article, the authors discuss the shortfalls of health care policies that guide glaucoma care and propose redefining innovation to keep an eye on patient access.

Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?

In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.